TickerFacts.

Johnson & Johnson (JNJ): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$7.50B
Year ended 2025-12-28
$7.75B
Trailing 12 months to 2026-06-28
+2.5%
3-year compound annual growth
+0.7%
5-year compound annual growth
+7.2%
10-year compound annual growth
2007-12-30: $2.78B2008-12-28: $2.83B2010-01-03: $2.77B2011-01-02: $2.94B2012-01-01: $3.16B2012-12-30: $3.67B2013-12-29: $4.10B2014-12-28: $3.90B2016-01-03: $3.75B2017-01-01: $3.75B2017-12-31: $5.64B2018-12-30: $6.93B2019-12-29: $7.01B2021-01-03: $7.23B2022-01-02: $7.39B2023-01-01: $6.97B2023-12-31: $7.49B2024-12-29: $7.34B2025-12-28: $7.50B$7.50B
2007-12-30 Depreciation & Amortization (USD) 2025-12-28
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-28$7.50B+2.2%2026-02-11, From 2024-12-30
2024-12-29$7.34B-2.0%2026-02-11, From 2024-01-01
2023-12-31$7.49B+7.4%2026-02-11, From 2023-01-02
2023-01-01, Fiscal 2022$6.97B-5.7%2025-02-13, From 2022-01-03
2022-01-02, Fiscal 2021$7.39B+2.2%2024-02-16, From 2021-01-04
2021-01-03, Fiscal 2020$7.23B+3.2%2023-02-16, From 2019-12-30
2019-12-29$7.01B+1.2%2022-02-17, From 2018-12-31
2018-12-30$6.93B+22.8%2021-02-22, From 2018-01-01
2017-12-31$5.64B+50.3%2020-02-18, From 2017-01-02
2017-01-01, Fiscal 2016$3.75B+0.2%2019-02-20, From 2016-01-04
2016-01-03, Fiscal 2015$3.75B-3.8%2018-02-21, From 2014-12-29
2014-12-28$3.90B-5.1%2017-02-27, From 2013-12-30
2013-12-29$4.10B+11.9%2016-02-24, From 2012-12-31
2012-12-30$3.67B+16.1%2015-02-24, From 2012-01-02
2012-01-01, Fiscal 2011$3.16B+7.5%2014-02-21, From 2011-01-03
2011-01-02, Fiscal 2010$2.94B+5.9%2013-02-22, From 2010-01-04
2010-01-03, Fiscal 2009$2.77B-2.0%2012-02-23, From 2008-12-29
2008-12-28$2.83B+2.0%2011-02-25, From 2007-12-31
2007-12-30$2.78Bn/a2010-03-01, From 2007-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Johnson & Johnson (JNJ)2025-12-28$7.50B+2.2%
Eli Lilly & Co (LLY)2025-12-31$2.00B+13.0%
Pfizer Inc (PFE)2025-12-31$6.59B-6.0%
Bristol Myers Squibb Co (BMY)2025-12-31$4.01B-58.2%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$1.00B-5.4%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$543.70M+12.6%
Viatris Inc (VTRS)2025-12-31$2.80B-3.3%
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$209.80M+1.3%
Bausch Health Companies Inc. (BHC)2025-12-31$1.21B-4.7%

Compare JNJ, LLY, PFE, BMY side by side · Screen every company in Pharmaceutical Preparations ↗